November 25, 2025 · Form 4 insider transaction
KLEIN JOSEPH III sold 4,000 shares of Ionis Pharmaceuticals, Inc. at $80.00 per share, a transaction worth $320.0K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 3 days after the transaction.
Shares sold pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on January 3, 2024; The reporting person disclaims beneficial ownership of all securities held in the children's trusts, and this report should not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.